Before asking a manufacturing partner for a price, decide what you need to buy. Finding the best biologics CDMOs starts with a clear program brief, not a list of familiar company names.
Use that brief to test each proposed site, team, scope, and schedule. This guide helps biopharma leaders build a research list, request comparable proposals, and put technical questions in front of the people responsible for answering them.
How should biopharma companies choose a biologics CDMO?
Evaluate the best biologics CDMOs against your molecule, development stage, required services, proposed manufacturing site, and delivery window. Request evidence for each requirement, compare quotes on the same scope, and have your CMC, quality, legal, and sourcing teams review the offer. Treat company lists as research leads, not a final ranking.
Which companies should enter your first research list?
Start your search for the best biologics CDMOs with named candidates, then narrow it through program-specific review. Mordor Intelligence's biologics CDMO company list names Boehringer Ingelheim, WuXi Biologics, Samsung Biologics, Lonza, and Fujifilm Diosynth Biotechnologies. AGC Biologics is another candidate to research. These names are a starting set, not an order of preference.
Give each candidate the same initial questions: Which site would perform the work? Which services are included? Who would lead the program? What evidence can the team provide for comparable work? What delivery window can it offer in writing?
For background on the outsourcing role, read what is a CDMO. Whether a provider uses CMO or CDMO in its name, evaluate the actual services in its proposal.
What should you define before contacting the best biologics CDMOs?
Write a short sourcing brief with your technical team. Give prospective partners enough detail to assess the work, while using your company's confidentiality process for sensitive information. Keep confirmed requirements separate from assumptions that still need testing.
Include:
- Product and process: Molecule type, expression system, current process, and available development data.
- Stage and deliverables: The next milestone, requested batches, testing work, and documentation.
- Scale and presentation: Target batch size and any vial, syringe, cartridge, or other presentation requirements.
- Timing and markets: Required delivery date, intended markets, and key dependencies.
- Handoffs: Work you will retain and work you want the partner to own.
Name an internal decision owner. Ask CMC, quality, procurement, and legal colleagues to identify their non-negotiable requirements before proposals arrive.
How should you evaluate the best biologics CDMOs?
Separate evidence review from commercial scoring. First test whether the proposed arrangement meets your requirements. Then compare the acceptable offers on scope, cost, governance, and flexibility.
Does the proposed site meet your quality requirements?
Ask the best biologics CDMOs on your shortlist for evidence tied to the facility proposed for your work. Request relevant inspection information, audit access, quality-system documentation, and an explanation of how deviations, change control, and subcontracted work would be handled. Have your quality team decide which records are needed and how to assess them.
Do not turn a company-wide credential into a site-level conclusion. Record the facility name, evidence date, scope, and reviewer for each finding. Route regulatory interpretations to the people responsible for your program's requirements.
Who owns development, analytics, and CMC support?
Request a work plan that names the owners of process development, analytical methods, testing, documentation, and technology transfer. Ask what the partner needs from your team before each stage can begin.
Use a technical meeting to examine open questions. Ask for the proposed experiment, decision point, or deliverable that would address each one. Keep claims of expertise separate from the work the team is offering to perform.
Is the schedule a commitment or an estimate?
When comparing the best biologics CDMOs, examine the steps behind the delivery date. Ask for milestones covering technical assessment, material readiness, transfer, manufacturing, testing, and release activities relevant to your scope.
Request the assumptions behind each date. Clarify capacity reservation, cancellation terms, rescheduling rules, and escalation ownership. Distinguish an indicative date from a date supported by an agreed reservation and contract.
Should the best biologics CDMOs handle fill-finish too?
Choose the scope deliberately. Ask each candidate whether its offer covers drug substance, drug product, fill-finish, or a defined combination. Identify the actual site and any third party proposed for each activity.
For a combined arrangement, ask who owns the handoffs and whether one program lead can resolve issues across stages. For separate partners, assign responsibility for transfer specifications, transport, testing, documentation, and schedule coordination. Have your technical and quality teams review the proposed interfaces before contracting.
Do not assume that a broader service list is a better fit. Compare the responsibilities you want to consolidate with the control and specialist input you want to retain.
Which approach fits enterprise, mid-market, and specialized buyers?
To find the best biologics CDMOs for your organization, compare the operating model as well as the technical offer. Use the profiles below to shape your questions—not to assign a company to a category by size alone.
| Buyer profile | Prioritize | Tradeoff to examine |
|---|---|---|
| Enterprise or multi-program buyer | Ask for portfolio governance, site responsibilities, escalation paths, and continuity planning. | Compare standardized processes with the flexibility each program requires. |
| Mid-market or lean biopharma team | Request a named program lead, clear deliverables, documentation support, and a defined division of work. | Compare work delegated to the partner with oversight your team must retain. |
| Specialized or technically demanding program | Examine the proposed approach to your specific process, analytical, formulation, or presentation challenge. | Compare specialist input with the coordination required across providers. |
Use company size as context, not as your selection rule. A small internal team should ask exactly which decisions remain its responsibility. A large buyer should still review the people and facility assigned to the individual program.
What do the best biologics CDMOs cost?
Build the budget from a defined scope and written quotes. Do not set it from a generic per-batch number. Ask each candidate to separate the requested work into comparable line items.
Request pricing for applicable activities such as:
- Development, analytical work, and technology transfer.
- Engineering work and planned manufacturing batches.
- Materials, consumables, testing, and documentation.
- Fill-finish, packaging, storage, and shipping.
- Capacity reservation, scope changes, cancellation, and additional support.
Mark every item as included, excluded, optional, or priced separately. Ask what would trigger a change order and who can authorize it. Compare payment milestones, currency, taxes, and the treatment of unused materials with your commercial team.
Compare the proposed cost to reach the same milestone—not simply the lowest headline price. Resolve differences in batch assumptions, testing, documentation, and handoffs before presenting a recommendation.
What should you send in a request for proposal?
Send the best biologics CDMOs on your working list one consistent request for proposal. Include your sourcing brief, a scope template, a response format, and the questions each internal reviewer needs answered.
Ask candidates to return:
- The proposed site, team, services, and subcontractors.
- A work plan with deliverables, dependencies, and assumptions.
- A schedule with reservation terms and decision deadlines.
- An itemized quote with exclusions and change-order rules.
- Proposed terms for data access, intellectual property, transfer support, and termination.
Budget internal time for technical meetings, quality review, commercial clarification, and contract negotiation. Assign an owner and due date to each open question. Have legal counsel assess contractual rights rather than treating this guide as contract advice.
What should a CDMO website tell a prospective buyer?
CDMO leaders targeting searches for the best biologics CDMOs should make buyer-relevant information easy to find. Explain service boundaries, site responsibilities, program intake, and the route to a technical conversation. Support capability statements with publishable evidence rather than broad claims of leadership.
For commercial teams, that is a useful brief for life sciences marketing: organize content around the questions buyers need answered before contacting you. Keep public explanations distinct from confidential material shared during diligence.
How do you make the final selection?
Choose among the best biologics CDMOs using a decision memo your team can defend. Summarize program fit, reviewed evidence, agreed scope, schedule assumptions, commercial terms, and remaining risks. Explain why the preferred offer meets your requirements and why the alternatives were not selected.
Before signing, reconcile the proposal, work plan, quality responsibilities, and contract. Give every unresolved requirement an owner and resolution path. Keep the final technical, quality, and contractual decisions with your qualified internal teams and advisers.
About the author
Bob Generale is President of Percepture.
